Hyperbaric oxygen: therapy for patients with maxillofacial implants?

Area of Science:

• Biomaterials Science
• Oral and Maxillofacial Surgery
• Regenerative Medicine

Background:

• Osseointegration is crucial for dental implant success, influenced by material biocompatibility, bone quality, surgical technique, and implant design.
• While successful in many cases, osseointegration faces challenges in patients undergoing radiation therapy due to adverse effects on bone tissue.
• Hyperbaric oxygen therapy (HBOT) is explored as a potential treatment to enhance bone and tissue preparation for implant integration.

Purpose of the Study:

• To conduct a literature review on the use of hyperbaric oxygen therapy in conjunction with maxillofacial implants.
• To evaluate the indications, contraindications, successes, and difficulties associated with HBOT in this context.

Main Methods:

• Literature review of existing studies and clinical data.
• Analysis of therapeutic outcomes and patient responses to HBOT combined with osseointegration.

Main Results:

• HBOT shows promise in preparing bone and surrounding tissues for dental implant placement, particularly in compromised bone conditions.
• Specific protocols and patient selection criteria are critical for maximizing HBOT efficacy.
• Potential difficulties include treatment duration, patient tolerance, and cost-effectiveness.

Conclusions:

• Hyperbaric oxygen therapy presents a viable adjunctive treatment to improve osseointegration success rates for maxillofacial implants.
• Further research is needed to establish optimal HBOT protocols and long-term outcomes in diverse patient populations, especially those with prior radiation exposure.